February 2026

6 February 2026

Call for Research Associate Position at NIPGR - Biochemistry, Life Sciences, Biotechnology apply

Doctoral degree in Molecular Biology / Biochemistry / Plant Science / Life Sciences / Biotechnology / Bioinformatics or equivalent from a recognized university or equivalent.

6 February 2026

Institute of Life Sciences looking for Project Associate

Master degree or equivalent in Science, Engineering or Technology with at least 60% marks or equivalent. The candidates with at least one of the national level competitive exams qualifications such as NET/GATE/GPAT etc will be given preference.

6 February 2026

HiMedia Laboratories Hiring Research Scientist

Development of new extraction kits on various extraction platforms. Upgradation of existing products in view of attributes such as, but not limiting to performance improvement, cost reduction, new feature.

6 February 2026

QA, Production, Packing Opportunities at Emcure

Handling of Change Controls, CAPA's, Unplanned Deviations, Planned Deviation, Investigations and Audit Management in Trackwise software

6 February 2026

Regulatory Affairs Jobs at BDR Pharmaceuticals

To have knowledge of ICH guidelines and other regional regulatory requirements including USFDA, EMA, NMPA, TGA, CADIFA and other global regulatory market.

6 February 2026

AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®)

The regulatory submissions to the FDA and EMA are supported by previously announced results from the Viti-Up studies evaluating the safety and efficacy of upadacitinib in patients with NSV.

6 February 2026

Alembic Pharma Wins USFDA Nod for Parkinson Combination Therapy Tablets

Alembic Pharmaceuticals Limited has strengthened its US generics portfolio with the final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) covering Carbidopa, Levodopa and Entacapone Tablets.

6 February 2026

Zydus Desidustat Secures USFDA Orphan Drug Status for Sickle Cell Therapy

Zydus Lifesciences has achieved a significant regulatory milestone as the U.S. Food and Drug Administration (USFDA) granted Orphan Drug Designation (ODD) to its novel molecule Desidustat for the treatment of Sickle Cell Disease (SCD). The designation highlights the growing recognition of the urgent need for new and effective therapies in this rare and challenging condition.

5 February 2026

Career for Bench Chemist at Regional Drugs Testing Laboratory

B.Pharmacy with experience or M.Pharma, Master Degree in Chemistry / Microbiology. Candidates having experience in testing of drugs will be given preference. The candidates should also have sound knowledge of computer operation.